Flesinoxan shows antidepressant activity in a DRL 72-s screen-Reference-Cited by-同舟云学术

Flesinoxan shows antidepressant activity in a DRL 72-s screen

Published:1992-06 Issue:4 Volume:107 Page:474-479
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

van Hest A.,van Drimmelen M.,Olivier B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF02245258.pdf

Reference32 articles.

1. Amsterdam JD, Berwish N, Potter L, Rickels K (1987) Open trial of gepirone in the treatment of major depressive disorder. Curr Ther Res Clin Exp 41:185–193

2. Barrett JE, Glesson S, Nader MA, Hoffmann SM (1989) Anticonflict effects of the 5-HT1A compound flesinoxan. J Psychopharmacol 3:64–69

3. Britton KT, Koob GF (1989) Effects of corticotropin releasing factor, desipramine and haloperidol on a DRL schedule of reinforcement. Pharmacol Biochem Behav 32:967–970

4. Cervo L, Grinaschi G, Samanin R (1988) 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur J Pharmacol 158:53–59

5. Chojnacka-Wójcik E, Tatarczynska E, Golembiowska K, Przegalinski E (1991) Involvement of 5-HT1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats. Neuropharmacology 30:711–718

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward a Quantification of Anhedonia: Unified Matching Law and Signal Detection for Clinical Assessment and Drug Development;Perspectives on Behavior Science;2021-05-19

2. Antidepressant Activity;Drug Discovery and Evaluation: Pharmacological Assays;2016

3. Antidepressant Activity;Drug Discovery and Evaluation: Pharmacological Assays;2016

4. Serotonin and inhibitory response control: Focusing on the role of 5-HT1A receptors;European Journal of Pharmacology;2015-04

5. Serotonin: A never-ending story;European Journal of Pharmacology;2015-04